Clinical Trial Update: Treatment-Resistant Depression Registry

View source ↗

Summary

Clinical trial NCT00320372, a treatment-resistant depression registry sponsored by Cyberonics, Inc., is reported as completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vagus nerve stimulation (VNS) system

Snippet

Sponsor: Cyberonics, Inc. | Conditions: Major Depressive Disorder | Status: COMPLETED | Results posted: 2015-12-23